ARCHIVES

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

This article is from The Cancer Letter archive.

Vol. 36 No. 42 | November 19, 2010

Download PDF Visit The Full Archive

Related Articles

“We’d Ban Cigarettes’ If Nicotine Were a Drug, FDA Commissioners Says

February 14, 1992

Cancer Registry Says Paper By Jon Sudbo Was Based On Fabricated Data.

January 27, 2006

Congress Approves FY 2010 Budget. Loehrer Named Interim Director At Indiana

April 10, 2009

NCI To Recompete Smokeless Tobaccos RFA as PA

January 24, 1986

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976